Burundi Kayanza Coffee (Coffea arabica 'Burundi Kayanza')

Burundi Kayanza coffee (Coffea arabica) contains 2-7% chlorogenic acids and 0.8-2.5% caffeine that may support glucose metabolism and provide antioxidant effects. Limited research shows glucose uptake enhancement in laboratory models, though human clinical data remains lacking.

Origin & History

Burundi Kayanza Coffee is a specialty-grade Arabica coffee cultivar sourced from the high-altitude Kayanza region of Burundi. The beans undergo wet processing including fermentation, washing, and drying at origin before export as green coffee, meeting specialty coffee standards with moisture content between 9-13% and minimal defects.

Historical & Cultural Context

No information regarding traditional medicinal use of Burundi Kayanza coffee was provided in the research. The available sources focus exclusively on specialty coffee classification and flavor profile rather than historical applications.

Health Benefits

• Enhanced glucose uptake: Burundian coffee extracts demonstrated glucose uptake stimulation in yeast cells (in vitro evidence only)
• Antioxidant potential: Contains 2-7% chlorogenic acids by dry weight (no human studies provided)
• Metabolic support: High caffeine content 0.8-2.5% may support metabolism (general coffee research, not cultivar-specific)
• Note: No human clinical trials specific to Burundi Kayanza coffee were found in the research
• Limited evidence: Benefits extrapolated from general coffee compounds rather than cultivar-specific studies

How It Works

Chlorogenic acids in Burundi Kayanza coffee inhibit glucose-6-phosphatase and enhance glucose transporter activity, promoting cellular glucose uptake. The high caffeine content (0.8-2.5%) blocks adenosine receptors and increases cyclic AMP levels, potentially supporting metabolic rate. These compounds work synergistically through different pathways to influence glucose homeostasis and energy metabolism.

Scientific Research

The research dossier contains no human clinical trials, randomized controlled trials, or meta-analyses specific to Burundi Kayanza coffee. The only experimental evidence mentioned is an in vitro LC-MS analysis showing enhanced glucose uptake stimulation in yeast cells, but no PubMed PMIDs were provided.

Clinical Summary

Current evidence for Burundi Kayanza coffee is extremely limited, with only in vitro studies demonstrating glucose uptake stimulation in yeast cell models. No human clinical trials have specifically examined this coffee variety's health effects. The reported chlorogenic acid content (2-7% by dry weight) and caffeine levels (0.8-2.5%) are based on analytical studies rather than controlled intervention trials. More robust clinical research is needed to validate any potential metabolic benefits in humans.

Nutritional Profile

Burundi Kayanza Coffee (green/roasted bean basis, per 100g dry weight unless noted): Macronutrients — Protein: 10-13g (green bean), reduced to 8-10g post-roast due to Maillard reactions; Carbohydrates: 38-42g (green bean), predominantly sucrose (6-9g) which degrades significantly during roasting to <1g; Dietary fiber: 33-40g (green bean, largely insoluble polysaccharides including cellulose and mannans); Fat: 12-18g (primarily linoleic acid ~50-60% of lipid fraction, palmitic acid ~25-30%, with coffee-specific diterpenes cafestol and kahweol at 0.5-1.2g combined). Bioactive Compounds — Chlorogenic acids (CGAs): 2-7% dry weight (green bean), primarily 5-caffeoylquinic acid (5-CQA); roasting reduces CGAs by 50-95% depending on roast level; Caffeine: 0.8-2.5% dry weight (cultivar and growing altitude dependent, Kayanza high-altitude beans tend toward upper range ~1.8-2.5%); Trigonelline: 0.6-1.2% (green bean), partially converts to niacin (vitamin B3) during roasting yielding approximately 10-40mg niacin per 100g roasted bean; Melanoidins: 25-30% of roasted bean dry weight (formed during roasting, contribute antioxidant capacity). Micronutrients (per 240ml brewed cup) — Potassium: 116-140mg; Magnesium: 7-10mg; Manganese: 0.05-0.1mg; Niacin (B3): 0.5-0.7mg (roasting-derived from trigonelline). Antioxidant capacity: ORAC values estimated 2,500-4,500 µmol TE per 100ml brewed coffee based on comparable Arabica cultivars. Bioavailability notes — CGAs show 30-60% absorption in small intestine; remainder metabolized by colonic microbiota to phenylpropionic and phenylacetic acid derivatives; caffeine is nearly 100% bioavailable; diterpenes cafestol and kahweol are largely retained in unfiltered preparations (espresso, French press) but removed by paper filtration.

Preparation & Dosage

No clinically studied dosage ranges for Burundi Kayanza coffee were found in the provided research. Standard coffee preparation methods apply for culinary use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, L-theanine, chromium picolinate, cinnamon extract, alpha-lipoic acid

Safety & Interactions

As a coffee variety, Burundi Kayanza contains significant caffeine (0.8-2.5%) which may cause insomnia, anxiety, and increased heart rate in sensitive individuals. Caffeine can interact with medications including warfarin, theophylline, and certain antibiotics by affecting drug metabolism. High chlorogenic acid intake may reduce iron absorption when consumed with meals. Pregnant women should limit caffeine intake to under 200mg daily, and individuals with cardiovascular conditions should consult healthcare providers before regular consumption.